Zyflamend (TM) for Prostate Cancer Prevention – Phase I Trial Results

Results of a phase I clinical trial of a unique herbal therapeutic called Zyflamend (TM) have demonstrated that the therapy is associated with minimal toxicity and no serious adverse events in men at high-risk for developing prostate cancer. The new findings,...

Jack Distribution Issues Recall Select Lots of Rize 2 The Occasion Capsules And Rose 4 Her Capsules

Jack Distribution and its wholesale distributors G & N works, Inc., and Devine Distribution, Inc., announced today that they are conducting a voluntary nationwide recall of the following lot numbers of the company’s supplement products sold...